Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Zeitschrift Fur Rheumatologie|January 24, 2024
[Hemophagocytic lymphohistiocytosis and macrophage activation syndrome : A multidisciplinary challenge]Nikolas Ruffer, Ricardo Kosch, Katja Weisel, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 28, 2025
Real-World Data on Outcome of Burkitt Lymphoma and Burkitt Leukemia Treated According to the GMALL B-ALL/NHL 2002 Protocol: A Tertiary Center ExperienceRicardo Kosch, Christoph Schaefers, Christian Frenzel, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 26, 2020
Long-term prognostic counselling in people with multiple sclerosis using an online analytical processing toolRicardo Kosch, Insa Schiffmann, Martin Daumer, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 15, 2026
Malignancy-Associated Hemophagocytic Lymphohistiocytosis: Clinical Characteristics, Treatment Patterns, and Survival Outcomes in a Tertiary Care Center CohortRicardo Kosch, Winfried Alsdorf, Paymon Ahmadi, et al.
Haematologica|September 25, 2025
Hepatitis E virus infections in people with multiple myeloma: an emerging challenge in the era of immunotherapeutic approachesMaximilian Al-Bazaz, Sven Pischke, Winfried Alsdorf, et al.
Annals of Hematology|June 16, 2026
Characteristics, treatment regimens, and outcomes of patients with true extramedullary multiple myeloma: a real-world monocentric analysisMarie Harzer, Nils Gross-Fengels, Fede Melzer, et al.
American Journal of Hematology|March 31, 2026
Navigating the Post-BCMA/GPRC5D Landscape: Efficacy of Selinexor, Bortezomib, and Dexamethasone After Sequential Immunotherapy Failure in Penta-Refractory Multiple Myeloma-A Multicenter AnalysisMaximilian Al-Bazaz, Winfried Alsdorf, Lisa Leypoldt, et al.
Blood Cancer Journal|July 30, 2025
Activity of CAR-T cells and bispecific antibodies in multiple myeloma with extramedullary involvementMaximilian J Steinhardt, Christoph Schaefers, Lisa B Leypoldt, et al.
Pageof 1